# The Role of Urinary RhoA, NGF, and BDNF Levels in Overactive Bladder and Vitamin D Deficiency

> **NCT07513363** · NA · NOT_YET_RECRUITING · sponsor: **Tarik Emre Sener** · enrollment: 52 (estimated)

## Conditions studied

- Overactive Bladder
- Vitamin D Deficiency

## Interventions

- **BEHAVIORAL:** Urotherapy

## Key facts

- **NCT ID:** NCT07513363
- **Lead sponsor:** Tarik Emre Sener
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-01
- **Primary completion:** 2026-12-01
- **Final completion:** 2027-01-01
- **Target enrollment:** 52 (ESTIMATED)
- **Last updated:** 2026-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07513363

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07513363, "The Role of Urinary RhoA, NGF, and BDNF Levels in Overactive Bladder and Vitamin D Deficiency". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT07513363. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*